banner


A yau, Hukumar Abinci da Magunguna ta Amurka tana ba da taƙaitaccen taƙaitaccen labarai daga ko'ina cikin hukumar:

  • A yau, FDA ta shawarci masu amfani game da haɗarin haɗari na haɗari, musamman ta yara, nakayayyakin abinci masu dauke da THC.Ciwon waɗannan samfuran da ake ci na bazata na iya haifar da munanan al'amura.
  • Yanzu, FDAbayarjagora na ƙarshe mai taken "Rage Hatsarin Tsaron Abinci na Ƙanƙara a cikin Samar da iri don tsiro: Jagorar Masana'antu.”Wannan jagorar ta fayyace babbar damuwar FDA game da barkewar cututtukan abinci da ke da alaƙa da amfani da ɗanyen tsiro mai daɗaɗɗa da sauƙi kuma yana ba kamfanoni matakan da aka ba da shawarar don hana lalata a duk lokacin samar da iri don tsiro.
  • A ranar Alhamis, FDAya ba da izinin tallanna sabbin samfuran taba guda shida ta hanyar Premarket Product Application (PMTA).FDA ta bayaroda da aka bayar (MGO)zuwa Kamfanin RJ Reynolds Vapor don Vuse Vibena'urar sigarida kuma rakiyar mai ɗanɗanon taba a rufee-ruwa kwaf, da kuma na'urarta ta Vuse Ciro e-cigare da kuma rakiyar mai daɗin sigari ta rufe.e-ruwakwafsa.FDA ta kuma ba da umarnin hana tallace-tallace zuwa Kamfanin RJ Reynolds Vapor don sauran Vuse Vibe da Vuse Ciro da yawa.e-cigare kayayyakin.Bugu da ƙari, samfuran ɗanɗanon menthol da kamfanin ya gabatar har yanzu suna ƙarƙashin nazarin FDA.
  • A ranar alhamis, FDA ta amince da dakatarwar da Radicava ORS (edaravone) ta baki don kula da ciwon ƙwayar cuta na amyotrophic (ALS).Radicava ORS sigar Radicava ce da ake gudanarwa ta baki, wacce ta kasanceasali an amince da shi a cikin 2017 azaman jiko (IV).don magance ALS, wanda aka fi sani da cutar Lou Gehrig.Radicava ORS mai sarrafa kansa ne kuma ana iya ɗauka a gida.Bayan azumi na dare, Radicava ORS yakamata a sha da safe da baki ko ta bututun ciyarwa.Maganin baka yana da tsarin sashi iri ɗaya kamar Radicava-wani tsarin jiyya na farko na allurai na yau da kullun na kwanaki 14, sannan kuma tsawon kwanaki 14 ba tare da magani ba da kuma zagayen jiyya na gaba wanda ya ƙunshi allurai na yau da kullun don 10 daga cikin kwanaki 14, biyo baya. ta kwanaki 14 marasa magani.Mafi yawan illolin da Radicava ke haifarwa sune bruising (contusions), matsalolin tafiya (damun tafiya), da ciwon kai.Gajiya kuma mai yiwuwa tasiri ne daga Radicava ORS.Radicava da Radicava ORS na iya samun munanan illolin da ke tattare da halayen rashin lafiyan da suka haɗa da amya, kurji, da ƙarancin numfashi.Ga marasa lafiya da sulfite hankali, sodium bisulfite-wani sashi a cikin Radicava da Radicava ORS-zai iya haifar da wani nau'i na rashin lafiyan halayen da zai iya zama barazanar rai.Therubuta bayanaiya haɗa da ƙarin bayani kan haɗari masu alaƙa da Radicava ORS.
  • A ranar Talata, daCibiyar FDAfor Drug Evaluation and Research (CDER) ta sanar da ƙaddamar da sabonHaɓaka Shirin Cures na Rare (ARC)..Hange na Shirin ARC na CDER yana sauri kuma yana haɓaka haɓakar ingantattun zaɓuɓɓukan magani masu aminci waɗanda ke magance rashin biyan buƙatun marasa lafiya da ke da ƙarancin cututtuka.Wannan wani yunƙuri ne na CDER mai fa'ida tare da wakilcin jagoranci daga ofisoshi da yawa a cikin Cibiyar.A cikin shekararsa ta farko, Shirin ARC na CDER zai mayar da hankali kan ƙarfafa haɗin gwiwa na ciki da na waje tare da masu ruwa da tsaki kuma za su yi hulɗa tare da ƙwararrun waje don taimakawa wajen gano hanyoyin magance ƙalubalen ci gaban cututtukan cututtuka.CDER yana da kyakkyawan fata game da makomar ci gaban cututtukan cututtukan da ba a taɓa gani ba kuma yana sa ido don ci gaba da wannan muhimmin aiki a ƙarƙashin sabon Shirin CDER ARC - tare da marasa lafiya, masu ba da kulawa, ƙungiyoyin bayar da shawarwari, masana ilimi, masana'antu, da sauran abokan tarayya - don magance manyan likitocin da ba a cika su ba. bukatun marasa lafiya da iyalai masu fama da cututtuka marasa yawa.
  • Sabunta gwajin COVID-19:
    • Ya zuwa yau, FDA ta ba da izini ga gwaje-gwaje 432 da na'urorin tattara samfuran a ƙarƙashin izinin amfani da gaggawa (EUAs).Waɗannan sun haɗa da gwaje-gwajen ƙwayoyin cuta guda 297 da na'urorin tattara samfuran, 84 antibody da sauran gwaje-gwajen amsa rigakafi, gwajin antigen 50, da gwajin numfashi guda 1.Akwai izini na ƙwayoyin cuta guda 77 da izini na rigakafi guda 1 waɗanda za a iya amfani da su tare da samfuran gida da aka tattara.Akwai 1 EUA don takardar sayan ƙwayoyin ƙwayoyin cuta a gida gwajin, 2 EUA don gwajin maganin antigen a gida, 17 EUA don gwaje-gwajen antigen kan-da-counter (OTC) a gida, da 3 don gwajin OTC na ƙwayoyin cuta a gida.
    • FDA ta ba da izinin gwaje-gwajen antigen guda 28 da gwaje-gwajen kwayoyin halitta 7 don shirye-shiryen tantancewa.FDA ta kuma ba da izini bita 968 zuwa izini na EUA.

Bayanai masu alaƙa

FDA, wata hukuma ce a cikin Ma'aikatar AmurkaLafiyada Sabis na Jama'a, suna kare lafiyar jama'a ta hanyar tabbatar da aminci, inganci, da amincin magungunan ɗan adam da na dabbobi, alluran rigakafi da sauran samfuran halittu don amfanin ɗan adam, da na'urorin likitanci.Haka kuma hukumar ita ce ke da alhakin kiyaye lafiyar al’ummarmu da kayan abinci, kayan kwalliya, kayan abinci, kayan da ke ba da hasken lantarki, da daidaita kayan sigari.

 


Lokacin aikawa: Mayu-21-2022